UP govt signs MoUs with CSIR, DRDO to promote research in medical sector
The state government has signed MoUs with 43 labs of CSIR and 46 labs of DRDO, where research work will be done to manufacture affordable medicines.
Number of MBBS seats in UP have doubled
Advertisement
Lucknow: The Yogi government in Uttar Pradesh is focusing on connecting the proposed Bulk Drugs Park in Lalitpur with technology along with research and innovation to provide high-quality and affordable medicines and medical devices.
For this, the government has linked big institutions of the Government of India like the Council of Scientific and Industrial Research (CSIR) and Defense Research and Development Organization (DRDO) with the Bulk Drug Park and made them its knowledge partners, according to the release.
It is noteworthy that as per the intention of CM Yogi, Bulk Drugs Park is being prepared as per international standards so that not only India but 196 countries worldwide can benefit from it and have access to affordable medicines and medical devices.
Moreover, the Yogi government has organized an Investors Connect webinar and signed an MOU with around 1,500 stakeholders to make the state a hub for the medical sector with the latest technology.
Research and innovation will get a boost in Lalitpur Bulk Drugs Park, CSIR and DRDO to become knowledge partners
Yogi govt will provide medicines and medical devices to the country and worldwide at high quality and affordable cost.
In order to make Lalitpur's Bulk Drugs Park high-tech, the Yogi government has made the country's renowned research institutions, CSIR and DRDO, knowledge partners, which will also enhance research and innovation in the medical sector. It will further enable the development of innovative devices through new technology, allowing for quick diagnosis of serious illnesses and ensuring proper treatment
Under this, the state government has signed MoUs with 43 labs of CSIR and 46 labs of DRDO, where research work will be done to manufacture affordable medicines. Discussions are also underway with the Biotechnology Department for knowledge tie-ups. Additionally, Adani Gas has been chosen as the PNG supply partner to create a nature-friendly zone for Bulk Drugs Park, while THDC has been selected as the solar power partner.
Moreover, CONCOR has been made the logistics partner, playing a crucial role in distributing medicines and medical devices nationally and internationally. Along with this, STPI will support Industry 4.0 to establish global recognition for the medical units in the park. Furthermore, Invest UP has been given the responsibility for policy support so that everyone can get the benefits of the new pharma policy of the Yogi government.
Yogi govt also organizes stakeholder meets to provide world-class facilities to entrepreneurs in Bulk Drugs Park
The Yogi government organized stakeholder meetings with about 150 stakeholders from India and abroad to provide world-class facilities to entrepreneurs in Bulk Drugs Park. These meets took place in Hyderabad, Mumbai, Japan, and America.
In these meetings, approximately 1505 stakeholders have signed MoUs to share their technology. Additionally, the Yogi government has decided to establish a Software Technology Park to strengthen the backbone of the medical sector's IT infrastructure.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.